Neximmune announces poster presentation at the 2023 focis annual meeting

Aim nanoparticle approach can identify select ebv-specific t cell defects in patients with multiple sclerosis and may enable killing of ebv+ cells believed to be a contributing factor in this disease

NEXI Ratings Summary

NEXI Quant Ranking